AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea · Delayed Price · Currency is KRW 4,495.00
-175.00 (-3.75%)
Nov 13, 2026, 3:30 PM KST
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 126.28 billion as of November 12, 2026. It is the 25,188th most valuable company in the world and the 1,059th biggest in South Korea. Its market cap has decreased by 36.35% in one year.
Market Cap
126.28B
Enterprise Value
115.47B
Revenue
4.75B
Global Rank
Country Rank
#1,059 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 126.28B, a decrease of -70.17%. That is a compound annual growth rate of -15.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 126.28B | -49.76% |
| Dec 30, 2025 | 251.34B | 46.78% |
| Dec 30, 2024 | 171.23B | -15.15% |
| Dec 28, 2023 | 201.80B | -15.02% |
| Dec 29, 2022 | 237.48B | -71.24% |
| Dec 30, 2021 | 825.71B | 46.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BNC KOREA | 155.94B |
| Dongwha Pharm.Co.,Ltd | 148.57B |
| Yungjin Pharm. | 148.33B |
| Daihan Pharmaceutical | 147.00B |
| Hana Pharm | 145.74B |
| Ilsung Is | 145.65B |
| Jeil Pharmaceutical Co.,Ltd | 131.02B |
| Ilyang Pharmaceutical Co.,Ltd | 122.25B |